Controlled Drugs and Substances Act

List of drugs

The list below reflects the list of drugs scheduled in Canada's Controlled Drugs and Substances Act.

On March 12, 2012, controversial Bill C-10, the Safe Streets and Communities Act was passed into law. Amphetamines and their isomers, derivatives, and analogues, including MDA and MDMA, as well as potential "date rape drugs" flunitrazepam and GHB were rescheduled from Schedule III to Schedule l. Dealers of Schedule I drugs now face mandatory minimum sentencing of 1 year imprisonment. Also, the rescheduling imposes harsher punishment for possession. For example; "Possession of substance

4 (1) Except as authorized under the regulations, no person shall possess a substance included in Schedule I, II or III.

Marginal note:Obtaining substance

(2) No person shall seek or obtain

(a) a substance included in Schedule I, II, III or IV, or

(b) an authorization to obtain a substance included in Schedule I, II, III or IV

from a practitioner, unless the person discloses to the practitioner particulars relating to the acquisition by the person of every substance in those Schedules, and of every authorization to obtain such substances, from any other practitioner within the preceding thirty days.

Marginal note:Punishment

(3) Every person who contravenes subsection (1) where the subject-matter of the offence is a substance included in Schedule I

(a) is guilty of an indictable offence and liable to imprisonment for a term not exceeding seven years; or

(b) is guilty of an offence punishable on summary conviction and liable

(i) for a first offence, to a fine not exceeding one thousand dollars or to imprisonment for a term not exceeding six months, or to both, and

(ii) for a subsequent offence, to a fine not exceeding two thousand dollars or to imprisonment for a term not exceeding one year, or to both."

Schedule I

Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:

1. Opium
2. Codeine (methylmorphine)
3. Morphine (7,8–didehydro–4,5–epoxy–17–methylmorphinan–3,6–diol)
4. Thebaine (paramorphine) and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:
5. Acetorphine (acetyletorphine)
6. Acetyldihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol acetate)
7. Benzylmorphine (7,8–didehydro–4,5–epoxy–17–methyl–3–(phenylmethoxy) morphinan–6–ol)
8. Codoxime (dihydrocodeinone O–(carboxymethyl) oxime)
9. Desomorphine (dihydrodeoxymorphine)
10. Diacetylmorphine (heroin)
11. Dihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol)
12. Dihydromorphine (4,5–epoxy–17–methylmorphinan–3,6–diol)
13. Ethylmorphine (7,8–didehydro–4,5–epoxy–3–ethoxy–17–methylmorphinan–6–ol)
14. Etorphine (tetrahydro–7α–(1–hydroxy–1–methyl-butyl)–6,14–endo–ethenooripavine)
15. Hydrocodone (dihydrocodeinone)
16. Hydromorphinol (dihydro–14–hydroxymorphine)
17. Hydromorphone (dihydromorphinone)
18. Methyldesorphine (Δ6–deoxy–6–methylmorphine)
19. Methyldihydromorphine (dihydro–6–methylmorphine)
20. Metopon (dihydromethylmorphinone)
21. Morphine–N–oxide (morphine oxide)
22. Myrophine (benzylmorphine myristate)
23. Nalorphine (N–allylnormorphine)
24. Nicocodine (6–nicotinylcodeine)
25. Nicomorphine (dinicotinylmorphine)
26. Norcodeine (N–desmethylcodeine)
27. Normorphine (N–desmethylmorphine)
28. Oxycodone (dihydrohydroxycodeinone)
29. Oxymorphone (dihydrohydroxymorphinone)
30. Pholcodine (3–[2–(4–morpholinyl)ethyl]morphine)
31. Thebacon (acetyldihydrocodeinone) but not including:
32. Apomorphine (5,6,6a,7–tetrahydro–6–methyl–4H–dibenzo[de,g]quinoline–10,11–diol)
33. Cyprenorphine (N–(cyclopropylmethyl)–6,7,8,14–tetrahydro–7α–(1–hydroxy–1–methylethyl)–6,14–endo–ethenonororipavine)
34. Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol)
    1. Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one)
    2. Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one)
35. Narcotine (6,7–dimethoxy–3–(5,6,7,8–tetra-hydro–4–methoxy–6–methyl–1,3–dioxolos [4,5–g]isoquinolin–5–yl)–1(3H)–isobenzofuranone)
36. Papaverine (1–[(3,4–dimethoxyphenyl)methyl]–6,7–dimethoxyisoquinoline)
37. Poppy seed

Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including:

1. Coca leaves
2. Cocaine (benzoylmethylecgonine)
3. Ecgonine (3–hydroxy–2–tropane carboxylic acid)

Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:

1. Allylprodine (3–allyl–1–methyl–4–phenyl–4–piperidinol propionate)
2. Alphameprodine (α–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
3. Alphaprodine (α–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
4. Anileridine (ethyl 1–[2–(p–aminophenyl)ethyl]–4–phenylpiperidine–4–carboxylate)
5. Betameprodine (β–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
6. Betaprodine (β–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
7. Benzethidine (ethyl 1–(2–benzyloxyethyl)–4–phenylpiperidine–4–carboxylate)
8. Diphenoxylate (ethyl 1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
9. Difenoxin (1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
10. Etoxeridine (ethyl 1–[2–(2–hydroxyethoxy) ethyl]–4–phenylpiperidine–4–carboxylate)
11. Furethidine (ethyl 1–(2–tetrahydrofurfury loxyethyl)–4–phenylpiperidine–4–carboxylate)
12. Hydroxypethidine (ethyl 4–(m–hydroxyphenyl)–1–methylpiperidine–4–carboxylate)
13. Ketobemidone (1–[4–(m–hydroxyphenyl)–1–methyl–4–piperidyl]–1–propanone)
14. Methylphenylisonipecotonitrile (4–cyano–1–methyl–4–phenylpiperidine)
15. Morpheridine (ethyl 1–(2–morpholinoethyl)–4–phenylpiperidine–4–carboxylate)
16. Norpethidine (ethyl 4–phenylpiperidine–4–carboxylate)
17. Pethidine (ethyl 1–methyl–4–phenylpiperidine–4–carboxylate)
18. Phenoperidine (ethyl 1–(3–hydroxy–3–phenylpropyl)–4–phenylpiperidine–4–carboxylate)
19. Piminodine (ethyl 1–[3–(phenylamino)propyl]–4–phenylpiperidine–4–carboxylate)
20. Properidine (isopropyl 1–methyl–4–phenylpiperidine–4–carboxylate)
21. Trimeperidine (1,2,5–trimethyl–4–phenyl–4–piperidinol propionate)
22. Pethidine Intermediate C (1–methyl–4–phenylpiperidine–4–carboxylate) but not including:
23. Carbamethidine (ethyl 1–(2–carbamylethyl)–4–phenylpiperidine–4–carboxylate)
24. Oxpheneridine (ethyl 1–(2–hydroxy–2–phenylethyl)–4–phenylpiperidine–4–carboxylate)

Phenazepines, their salts, derivatives and salts of derivatives including:

1. Proheptazine (hexahydro–1,3–dimethyl–4–phenyl–1H–azepin–4–ol propionate) but not including:
2. Ethoheptazine (ethyl hexahydro–1–methyl–4–phenyl–azepine–4–carboxylate)
3. Metethoheptazine (ethyl hexahydro–1,3–dimethyl–4–phenylazepine–4–carboxylate)
4. Metheptazine (ethyl hexahydro–1,2–dimethyl–4–phenylazepine–4–carboxylate)

Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including:

1. Dimethylaminodiphenylbutanonitrile (4–cyano–2–dimethylamino–4,4–diphenylbutane)
2. Dipipanone (4,4–diphenyl–6–piperidino–3–heptanone)
3. Isomethadone (6–dimethylamino–5–methyl–4,4–diphenyl–3–hexanone)
4. Methadone (6–dimethylamino–4,4–diphenyl–3–heptanone)
5. Normethadone (6–dimethylamino–4,4–diphenyl–3–hexanone)
6. Norpipanone (4,4–diphenyl–6–piperidino–3–hexanone)
7. Phenadoxone (6–morpholino–4,4–diphenyl–3–heptanone)

Methadols, their salts, derivatives and salts of derivatives including:

1. Acetylmethadol (6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
2. Alphacetylmethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
3. Alphamethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol)
4. Betacetylmethadol (β–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
5. Betamethadol (β–6–dimethylamino–4,4–diphenyl–3–heptanol)
6. Dimepheptanol (6–dimethylamino–4,4–diphenyl–3–heptanol)
7. Noracymethadol (α–6–methylamino–4,4–diphenyl–3–heptanol acetate)

Phenalkoxams, their salts, derivatives and salts of derivatives including:

1. Dimenoxadol (dimethylaminoethyl 1–ethoxy–1,1–diphenylacetate)
2. Dioxaphetyl butyrate (ethyl 2,2–diphenyl–4–morpholinobutyrate)
3. Dextropropoxyphene ([S–(R*,S*)]–α–[2–(dimethylamino)–1–methylethyl]–α–phenylbenzeneethanol, propanoate ester)

Thiambutenes, their salts, derivatives and salts of derivatives including:

1. Diethylthiambutene (N,N–diethyl–1–methyl–3,3–di–2–thienylallylamine)
2. Dimethylthiambutene (N,N,1–trimethyl–3,3–di–2–thienylallylamine)
3. Ethylmethylthiambutene (N–ethyl–N,1–dimethyl–3,3–di–2–thienylallylamine)

Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:

1. Dextromoramide (d–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
2. Diphenylmorpholinoisovaleric acid (2–methyl–3–morpholino–1,1–diphenylpropionic acid)
3. Levomoramide (l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
4. Racemoramide (d,l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl) pyrrolidine)

Morphinans, their salts, derivatives and salts of derivatives including:

1. Buprenorphine (17–(cyclopropylmethyl)–α–(1,1–dimethylethyl)–4,5–epoxy–18,19–dihydro–3–hydroxy–6–methoxy–α–methyl–6,14–ethenomorphinan–7–methanol)
2. Drotebanol (6β,14–dihydroxy–3,4–dimethoxy–17–methylmorphinan)
3. Levomethorphan (l–3–methoxy–17–methylmorphinan)
4. Levorphanol (l–3–hydroxy–17–methylmorphinan)
5. Levophenacylmorphan (l–3–hydroxy–17–phenacylmorphinan)
6. Norlevorphanol (l–3–hydroxymorphinan)
7. Phenomorphan (3–hydroxy–17–(2–phenylethyl)morphinan)
8. Racemethorphan (d,1–3–methoxy–17–methylmorphinan)
9. Racemorphan (d,l–3–hydroxy–N–methylmorphinan) but not including:
10. Dextromethorphan (d–1,2,3,9,10,10a–hexahydro–6–methoxy–11–methyl–4H–10,4a–iminoethano–phenanthren)
11. Dextrorphan (d–1,2,3,9,10,10a–hexahydro–11–methyl–4H–10,4a–iminoethanophenanthren–6–ol)
12. Levallorphan (l–11–allyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol)
13. Levargorphan (l–11–propargyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol)
14. Butorphanol (17–(cyclobutylmethyl)morphinan–3,14–diol)
15. Nalbuphine (17–(cyclobutylmethyl)–4,5α–epoxymorphinan–3,6α, 14–triol)

Benzazocines, their salts, derivatives and salts of derivatives including:

1. Phenazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–phenethyl–2,6–methano–3–benzazocin–8–ol)
2. Metazocine (1,2,3,4,5,6–hexahydro–3,6,11–trimethyl–2,6–methano–3–benzazocin–8–ol)
3. Pentazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(3–methyl–2–butenyl)–2,6–methano–3–benzazocin–8–ol)

but not including

1. Cyclazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(cyclopropylmethyl)–2,6–methano–3–benzazocin–8–ol)

Ampromides, their salts, derivatives and salts of derivatives including:

1. Diampromide (N–[2–(methylphenethylamino)propyl] propionanilide)
2. Phenampromide (N–(1–methyl–2–piperidino) ethyl) propionanilide)
3. Propiram (N–(1–methyl–2–piperidinoethyl)–N–2–pyridylpropionamide)

Benzimidazoles, their salts, derivatives and salts of derivatives including:

1. Clonitazene (2–(p–chlorobenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
2. Etonitazene (2–(p–ethoxybenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
3. Bezitramide (1–(3–cyano–3,3–diphenylpropyl)–4–(2–oxo–3–propionyl–1–benzimidazolinyl)–piperidine)

Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:

1. Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)

Piritramide (1–(3–cyano–3,3–diphenylpropyl)–4–(1–piperidino)piperidine–4–carboxylic acid amide), its salts, derivatives and salts of derivatives

Fentanyls, their salts, derivatives, and analogues and salts of derivatives and analogues, including:

1. Acetyl–α–methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] acetanilide)
2. Alfentanil (N–[1–[2–(4–ethyl–4,5–dihydro–5–oxo–1H–tetrazol–1–yl)ethyl]–4–(methoxymethyl)–4–piperidyl]propionanilide)
3. Carfentanil (methyl 4–[(1–oxopropyl)phenylamino]–1–(2–phenethyl)–4–piperidinecarboxylate)
4. p–Fluorofentanyl (4′fluoro–N–(1–phenethyl–4–piperidyl) propionanilide)
5. Fentanyl (N–(1–phenethyl–4–piperidyl) propionanilide)
6. β–Hydroxyfentanyl (N–[1–(β–hydroxyphenethyl)–4–piperidyl] propionanilide)
7. β–Hydroxy–3–methylfentanyl (N–[1–(β–hydroxyphenethyl)–3–methyl–4–piperidyl] propionanilide)
8. α–Methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] propionanilide)
9. α–Methylthiofentanyl (N–[1–[1–methyl–2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
10. 3–Methylfentanyl (N–(3–methyl–1–phenethyl–4–piperidyl) propionanilide)
11. 3–Methylthiofentanyl (N–[3–methyl–1–[2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
    1. Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
12. Sufentanil (N–[4–(methoxymethyl)–1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)
13. Thiofentanyl (N–[1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)

Tilidine (ethyl2–(dimethylamino)–1–phenyl–3–cyclohexene–1–carboxylate), its salts, derivatives and salts of derivatives

1. Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:

1. Amphetamine (α-methylbenzene-ethanamine)
2. N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
3. 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
4. 3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
5. 2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
6. 4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine)
7. 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine)
8. N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
9. 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
10. 5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
11. N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
12. N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
13. 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
14. 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
15. 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
16. 4-ethoxyamphetamine (4-ethoxy-α-methylbenzeneethanamine)
17. Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine)
18. N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
19. N-(2-Hydroxyethyl)-α-meth-ylbenzeneethanamine
20. N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
21. 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)

Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives

4-hydroxybutanoic acid (GHB) and any of its salts

Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers

Schedule II

Cannabis, its preparations and derivatives, including

1. Cannabis resin
2. Cannabis (marijuana)
3. Cannabidiol (2–[3–methyl–6–(1–methylethenyl)–2–cyclohexen–1–yl]–5–pentyl–1,3–benzenediol)
4. Cannabinol (3–n–amyl–6,6,9–trimethyl–6–dibenzopyran–1–ol)
5. [Repealed, SOR/2015-192, s. 1]
6. [Repealed, SOR/2015-192, s. 1]
7. Tetrahydrocannabinol (tetrahydro–6,6,9–trimethyl–3–pentyl–6H–dibenzo[b,d]pyran–1–ol)
   1. [Repealed, SOR/2015-192, s. 1] but not including:
8. Non–viable Cannabis seed, with the exception of its derivatives
9. Mature Cannabis stalks that do not include leaves, flowers, seeds or branches; and fiber derived from such stalks

Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts — including those that fall within the following core chemical structure classes:

1. Any substance that has a 2-(cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3’-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including
   1. Nabilone ((±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
   2. Parahexyl (3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)
   3. 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
   4. 5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol (CP 55,940)
   5. 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497)
2. Any substance that has a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
   1. 1-pentyl-3-(1-naphthoyl)indole (JWH-018)
   2. 1-butyl-3-(1-naphthoyl)indole (JWH-073)
   3. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)
   4. 1-hexyl-3-(1-naphthoyl)indole (JWH-019)
   5. 1-(4-pentenyl)-3-(1-naphthoyl)indole (JWH-022)
   6. 1-butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-080)
   7. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081)
   8. 1-(2-morpholin-4-ylethyl)-3-(1-naphthoyl)indole (JWH-200)
   9. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210)
   10. 1-pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)
   11. 1-[(N-methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220)
   12. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201)
   13. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201)
   14. 1-(5-fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201)
   15. ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-2)
3. Any substance that has a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
   1. 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole (JWH-307)
4. Any substance that has a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
   1. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)
   2. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251)
   3. 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302)
5. Any substance that has a 3-benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
   1. 1-(1-methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole (AM-2233)
6. Any substance that has a 3-methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including
   1. (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144)
   2. (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144)
   3. (1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (A-796,260)
7. Any substance that has a quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including
   1. 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22)
   2. 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22)
8. Any substance that has a 3-carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
   1. N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)
   2. N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB48)
   3. N-(1-(aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)
   4. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)
9. Any substance that has a 3-carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
   1. N-(adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135)
   2. N-(adamantan-1-yl)-1-pentylindole-3-carboxamide (APICA)

Schedule III

[Repealed, 2012, c. 1, s. 45]

Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof

Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof

Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof

LSD (Lysergic acid diethylamide) (N,N–diethyllysergamide) and any salt thereof

DET (N,N–Diethyltryptamine) (3–[(2–diethylamino) ethyl]indole) and any salt thereof

DMT (N,N–Dimethyltryptamine) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof

N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof

Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof

Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof

Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof

Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof

PCE (N–(1–phenylcyclohexyl)ethylamine) and any salt thereof

TCP (1–[1–(2–Thienyl) cyclohexyl]piperidine) and any salt thereof

PCPr (1–Phenyl–N–propylcyclohexanamine) and any salt thereof

Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof

Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)

4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof

Cathinone ((–)–α–aminopropiophenone) and any salt thereof

Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof

Methcathinone (2–Methylamino–1–phenyl–1–propanone) and any salt thereof

Benzylcyclidine (1–[1–(Phenylmethyl)cyclohexyl]piperidine) and any salt thereof

4-methyl-PCP (1–[1–(4–Methylphenyl)cyclohexyl]piperidine) and any salt thereof

2C-B (4–bromo–2,5–dimethoxybenzeneethanamine) and any salt, isomer or salt of isomer thereof

[Repealed, 2012, c. 1, s. 46]

[Repealed, 2012, c. 1, s. 46]

Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof

Etryptamine (3-(2-aminobutyl)indole) and any salt thereof

Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof

Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof

Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof

Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof

BZP (Benzylpiperazine) (1-benzylpiperazine) and its salts, isomers and salts of isomers

TFMPP (Trifluoromethylphenylpiperazine) (1-(3-trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers

Schedule IV

Barbiturates, their salts and derivatives including

1. Allobarbital (5,5–diallylbarbituric acid)
2. Alphenal (5–allyl–5–phenylbarbituric acid)
3. Amobarbital (5–ethyl–5–(3–methylbutyl)barbituric acid)
4. Aprobarbital (5–allyl–5–isopropylbarbituric acid)
5. Barbital (5,5–diethylbarbituric acid)
6. Barbituric Acid (2,4,6(1H,3H,5H)–pyrimidinetrione)
7. Butabarbital (5–sec–butyl–5–ethylbarbituric acid)
8. Butalbital (5–allyl–5–isobutylbarbituric acid)
9. Butallylonal (5–(2–bromoallyl)–5–sec–butylbarbituric acid)
10. Butethal (5–butyl–5–ethylbarbituric acid)
11. Cyclobarbital (5–(1–cyclohexen–1–yl)–5–ethylbarbituric acid)
12. Cyclopal (5–allyl–5–(2–cyclopenten–1–yl)barbituric acid)
13. Heptabarbital (5–(1–cyclohepten–1–yl)–5–ethylbarbituric acid)
14. Hexethal (5–ethyl–5–hexylbarbituric acid)
15. Hexobarbital (5–(1–cyclohexen–1–yl)–1,5–dimethylbarbituric acid)
16. Mephobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)
17. Methabarbital (5,5–diethyl–1–methylbarbituric acid)
18. Methylphenobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)
19. Propallylonal (5–(2–bromoallyl)–5–isopropylbarbituric acid)
20. Pentobarbital (5–ethyl–5–(1–methylbutyl)barbituric acid)
21. Phenobarbital (5–ethyl–5–phenylbarbituric acid)
22. Probarbital (5–ethyl–5–isopropylbarbituric acid)
23. Phenylmethylbarbituric Acid (5–methyl–5–phenylbarbituric acid)
24. Secobarbital (5–allyl–5–(1–methylbutyl)barbituric acid)
25. Sigmodal (5–(2–bromoallyl)–5–(1–methylbutyl) barbituric acid)
26. Talbutal (5–allyl–5–sec–butylbarbituric acid)
27. Vinbarbital (5–ethyl–5–(1–methyl–1–butenyl)barbituric acid)
28. Vinylbital (5–(1–methylbutyl)–5–vinylbarbituric acid)

Thiobarbiturates, their salts and derivatives including:

1. Thialbarbital (5–allyl–5–(2–cyclohexen–1–yl)–2–thiobarbituric acid)
2. Thiamylal (5–allyl–5–(1–methylbutyl)–2–thiobarbituric acid)
3. Thiobarbituric Acid (2–thiobarbituric acid)
4. Thiopental (5–ethyl–5–(1–methylbutyl)–2–thiobarbituric acid)

Chlorphentermine (1–(p–chlorophenyl)–2–methyl–2–aminopropane) and any salt thereof

Diethylpropion (2–(diethylamino)propiophenone) and any salt thereof

Phendimetrazine (d–3,4–dimethyl–2–phenylmorpholine) and any salt thereof

Phenmetrazine (3–methyl–2–phenylmorpholine) and any salt thereof

Pipradol (α,α–diphenyl–2–piperidinemethanol) and any salt thereof

Phentermine (α,α–dimethylbenzeneethanamine) and any salt thereof

Butorphanol (l–N–cyclobutylmethyl–3,14–dihydroxymorphinan) and any salt thereof

Nalbuphine (N–cyclobutylmethyl–4,5–epoxy–morphinan–3,6,14–triol) and any salt thereof

Glutethimide (2–ethyl–2–phenylglutarimide)

Clotiazepam (5–(o–chlorophenyl)–7–ethyl–1,3–dihydro–1–methyl–2H–thieno[2,3–e]–1,4–diazepin–2–one) and any salt thereof

Ethchlorvynol (ethyl–2–chlorovinyl ethynyl carbinol)

Ethinamate (1–ethynylcyclohexanol carbamate)

Mazindol (5–(p–chlorophenyl)–2,5–dihydro–3H–imidazo[2,1–a]isoindol–5–ol)

Meprobamate (2–methyl–2–propyl–1,3–propanediol dicarbamate)

Methyprylon (3,3–diethyl–5–methyl–2,4–piperidinedione)

Benzodiazepines, their salts and derivatives, including:

1. Alprazolam (8–chloro–1–methyl–6–phenyl–4H–s–triazolo[4,3–a][1,4] benzodiazepine)
2. Bromazepam (7–bromo–1,3–dihydro–5–(2–pyridyl)–2H–1, 4–benzodiazepin–2–one)
   1. Brotizolam (2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
3. Camazepam (7–chloro–1,3–dihydro–3–(N,N– dimethylcarbamoyl)–1–methyl–5–phenyl–2H–1, 4–benzodiazepin–2–one)
4. Chlordiazepoxide (7–chloro–2–(methylamino)–5–phenyl–3H–1,4–benzodiazepine–4–oxide)
5. Clobazam (7–chloro–1–methyl–5–phenyl–1H–1,5–benzodiazepine–2,4(3H,5H)–dione)
6. Clonazepam (5–(o–chlorophenyl)–1,3–dihydro–7–nitro–2H–1,4–benzodiazepin–2–one)
7. Clorazepate (7–chloro–2,3–dihydro–2,2–dihydroxy–5–phenyl–1H–1,4–benzodiazepine–3–carboxylic acid)
8. Cloxazolam (10–chloro–11b–(o–chlorophenyl)–2,3, 7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin 6–(5H)–one)
9. Delorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)
10. Diazepam (7–chloro–1,3–dihydro–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)
11. Estazolam (8–chloro–6–phenyl–4H–s–triazolo [4,3–a][1,4]benzodiazepine)
12. Ethyl Loflazepate (ethyl 7–chloro–5–(o–fluorophenyl)–2,3–dihydro–2–oxo–1H–1,4–benzodiazepine–3–carboxylate)
13. Fludiazepam (7–chloro–5–(o–fluorophenyl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)
14. [Repealed, SOR/98-173, s. 2]
15. Flurazepam (7–chloro–1–[2–(diethylamino) ethyl]–5–(o–fluorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)
16. Halazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2,2,2–trifluoroethyl)–2H–1,4–benzodiazepin–2–one)
17. Haloxazolam (10–bromo–11b–(o–fluorophenyl)–2,3,7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin–6(5H)–one)
18. Ketazolam (11–chloro–8,12b–dihydro–2,8–dimethyl–12b–phenyl–4H–[1,3]–oxazino–[3,2–d][1,4] benzodiazepine–4,7(6H)–dione)
19. Loprazolam (6–(o–chlorophenyl)–2,4–dihydro–2–[(4–methyl–1–piperazinyl)methylene]–8–nitro–1H–imidazo[1,2–a][1,4]benzodiazepin–1–one)
20. Lorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–2H–1,4–benzodiazepin–2–one)
21. Lormetazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–1–methyl–2H–1,4–benzodiazepin–2–one)
22. Medazepam (7–chloro–2,3–dihydro–1–methyl–5–phenyl–1H–1,4–benzodiazepine)
    1. Midazolam (8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)
23. Nimetazepam (1,3–dihydro–1–methyl–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)
24. Nitrazepam (1,3–dihydro–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)
25. Nordazepam (7–chloro–1,3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)
26. Oxazepam (7–chloro–1,3–dihydro–3–hydroxy–5–phenyl–2H–1,4–benzodiazepin–2–one)
27. Oxazolam (10–chloro–2,3,7,11b–tetrahydro–2–methyl–11b–phenyloxazolo[3,2–d] [1,4]benzodiazepin–6(5H)–one)
28. Pinazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2–propynyl)–2H–1,4–benzodiazepin–2–one)
29. Prazepam (7–chloro–1–(cyclopropylmethyl)–1, 3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)
    1. Quazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione)
30. Temazepam (7–chloro–1,3–dihydro–3–hydroxy–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)
31. Tetrazepam (7–chloro–5–(cyclohexen–1–yl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)
32. Triazolam (8–chloro–6–(o–chlorophenyl)–1–methyl–4H–s–triazolo[4,3–a][1,4]benzodiazepine) but not including:
    1. Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and any salt thereof
33. Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
34. Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts

Catha edulis Forsk., its preparations, derivatives, alkaloids and salts, including:

1. Cathine (d–threo–2–amino–1–hydroxy–1–phenylpropane)

Fencamfamin (d,l–N–ethyl–3–phenylbicyclo[2,2,1] heptan–2–amine) and any salt thereof

Fenproporex (d,l–3–[(α–methylphenethyl)amino]propionitrile) and any salt thereof

Mefenorex (d,l–N–(3–chloropropyl)–α–methylbenzeneethanamine) and any salt thereof

Anabolic steroids and their derivatives including:

1. Androisoxazole (17ß–hydroxy–17α–methylandrostano [3,2–c]isoxazole)
2. Androstanolone (17ß–hydroxy–5α–androstan–3–one)
3. Androstenediol (androst–5–ene–3ß,17ß–diol)
4. Bolandiol (estr–4–ene–3ß,17ß–diol)
5. Bolasterone (17ß–hydroxy–7α,17–dimethylandrost–4–en–3–one)
6. Bolazine (17ß–hydroxy–2α–methyl–5α–androstan–3–one azine)
7. Boldenone (17ß–hydroxyandrosta–1,4–dien–3–one)
8. Bolenol (19–nor–17α–pregn–5–en–17–ol)
9. Calusterone (17ß–hydroxy–7ß,17–dimethylandrost–4–en–3–one)
10. Clostebol (4–chloro–17ß–hydroxyandrost–4–en–3–one)
11. Drostanolone (17ß–hydroxy–2α–methyl–5α–androstan–3–one)
12. Enestebol (4, 17ß–dihydroxy–17–methylandrosta–1,4–dien–3–one)
13. Epitiostanol (2α, 3α–epithio–5α–androstan–17ß–ol)
14. Ethylestrenol (19–nor–17α–pregn–4–en–17–ol)
15. 4–Hydroxy–19–nor testosterone
16. Fluoxymesterone (9–fluoro–11ß,17ß–dihydroxy–17–methylandrost–4–en–3–one)
17. Formebolone (11α, 17ß–dihydroxy–17–methyl–3–oxoandrosta–1,4 di–en–2–carboxaldehyde)
18. Furazabol (17–methyl–5α–androstano[2,3–c] furazan–17ß–ol)
19. Mebolazine (17ß–hydroxy–2α,17–dimethyl–5α–androstan–3–one azine)
20. Mesabolone (17ß–[(1–methoxycyclohexyl)oxy]–5α–androst–1–en–3–one)
21. Mesterolone (17ß–hydroxy–1α–methyl–5α–androstan–3–one)
22. Metandienone (17ß–hydroxy–17–methylandrosta–1,4–dien–3–one)
23. Metenolone (17ß–hydroxy–1–methyl–5α–androst–1–en–3–one)
24. Methandriol (17α–methylandrost–5–ene–3ß,17ß–diol)
25. Methyltestosterone (17ß–hydroxy–17–methylandrost–4–en–3–one)
26. Metribolone (17ß–hydroxy–17–methylestra–4, 9,11–trien–3–one)
27. Mibolerone (17ß–hydroxy–7α,17–dimethylestr–4–en–3–one)
28. Nandrolone (17ß–hydroxyestr–4–en–3–one)
29. Norboletone (13–ethyl–17ß–hydroxy–18, 19–dinorpregn–4–en–3–one)
30. Norclostebol (4–chloro–17ß–hydroxyestr–4–en–3–one)
31. Norethandrolone (17α–ethyl–17ß–hydroxyestr–4–en–3–one)
32. Oxabolone (4,17ß–dihydroxyestr–4–en–3–one)
33. Oxandrolone (17ß–hydroxy–17–methyl–2–oxa–5α–androstan–3–one)
34. Oxymesterone (4,17ß–dihydroxy–17–methylandrost–4–en–3–one)
35. Oxymetholone (17ß–hydroxy–2–(hydroxymethylene)–17–methyl–5α–androstan–3–one)
36. Prasterone (3ß–hydroxyandrost–5–en–17–one)
37. Quinbolone (17ß–(1–cyclopenten–1–yloxy) androsta–1,4–dien–3–one)
38. Stanozolol (17ß–hydroxy–17–methyl–5α–androstano [3,2–c]pyrazole)
39. Stenbolone (17ß–hydroxy–2–methyl–5α–androst–1–en–3–one)
40. Testosterone (17ß–hydroxyandrost–4–en–3–one)
41. Tibolone ((7α,17α)-17–hydroxy–7–methyl–19–norpregn–5(10) en–20–yn–3–one)
42. Tiomesterone (1α,7α–bis(acetylthio)–17ß –hydroxy–17–methylandrost–4–en–3–one)
43. Trenbolone (17ß–hydroxyestra–4,9,11–trien–3–one)

Zeranol (3,4,5,6,7,8,9,10,11,12–decahydro–7,14,16– trihydroxy–3–methyl–1H–2–benzoxacyclotetradecin–1–one)

Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof

1. Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof

Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof

Salvia divinorum (S. divinorum), its preparations and derivatives, including:

1. Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)

Schedule V

[Repealed, SOR/2002-361, s. 1]

Propylhexedrine (1–cyclohexyl–2–methylaminopropane) and any salt thereof

[Repealed, SOR/2003-32, s. 7]

PART 1

Class A Precursors

Acetic anhydride

N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts

Anthranilic acid (2-aminobenzoic acid) and its salts

Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts

Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts

Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts

Isosafrole (5-(1-propenyl)-1,3-benzodioxole)

Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts

3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone)

Norephedrine (Phenylpropanolamine) and its salts

1-Phenyl-2-propanone

Phenylacetic acid and its salts

Piperidine and its salts

Piperonal (1,3-benzodioxole-5-carboxaldehyde)

Potassium permanganate

Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts

Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole

Gamma-butyrolactone (dihydro-2(3H)-furanone)

1,4-butanediol

Red Phosphorus

White Phosphorus

Hypophosphorous acid, its salts and derivatives

Hydriodic acid

Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers

PART 2

Class B Precursors

Acetone

Diethyl ether

Hydrochloric acid

Methyl ethyl ketone

Sulphuric acid

Toluene

PART 3

Preparations and Mixtures

Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23 [Red Phosphorus; White Phosphorus; Hypophosphorous acid, its salts and derivatives; Hydriodic acid], or in Part 2.

Possession

If treated as an indictable offence, the penalty is:

Schedule I: Maximum 7 years imprisonment
Schedule II: (exceeding amounts set in Schedule VIII): Maximum 5 years imprisonment
Schedule III: (Requires a prescription or license to legally possess.) Maximum 3 years imprisonment
Schedule IV: It is not an indictable offence to possess a Schedule IV substance for personal use.

If treated as a summary conviction offence, the penalty is:

Schedule I, II, or III: Maximum $1000 fine for the first offence and/or a maximum 6-month term of imprisonment, increasing to a maximum fine of $2000 for each subsequent offense and/or a maximum of 1 year in prison.
Schedule IV: It is not a summary offence to possess a Schedule IV substance for personal use.

Note: For amounts not exceeding those set in Schedule VIII, maximum fine of $1000 and/or maximum 6 months imprisonment is the only punishment.

It should also be noted that Section (4), Subsection (2) of the CDSA reads that any person who obtains or who makes any attempt to obtain a Schedule I through IV substance from a physician without fully disclosing the details of any previous instances of obtaining a Schedule I through IV substance in the preceding thirty (30) days, a practice often referred to as "doctor shopping", is guilty of a summary or indictable offense, as per Section (4), Subsection (7)(a) and (b).

Trafficking/Possession for the Purpose of

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II (exceeding amounts set in Schedule VII): Maximum life imprisonment

Mandatory minimum 1-year jail sentence for trafficking a Schedule I drug under 1 kg, 2 years if amount exceeds 2 kg

Schedule II (not exceeding amounts set in Schedule VII): Maximum 5 years imprisonment
Schedule III: Maximum 10 years imprisonment
Schedule IV: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III: Maximum 18 months imprisonment
Schedule IV: Maximum 1 year imprisonment

Exportation/Possession for the Purpose of

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II: Maximum life imprisonment
Schedule III or Schedule IV: Maximum 10 years imprisonment
Schedule V or Schedule VI: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III or Schedule IV: Maximum 18 months imprisonment
Schedule V or Schedule VI: Maximum 1 year imprisonment

Production

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II (excluding cannabis): Maximum life imprisonment
Cannabis: Maximum 7 years imprisonment
Schedule III: Maximum 10 years imprisonment
Schedule IV: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III: Maximum 18 months imprisonment
Schedule IV: Maximum 1 year imprisonment

Amendments to the act

In November 2007, the Justice Minister Rob Nicholson introduced Bill C-26, which proposed a number of mandatory minimum penalties imposed on those who commit drug offences. On February 27, 2009 bill C-15, a re-introduction of C-26 received first reading in the 2nd Session of the 40th Parliament of Canada. On June 9, 2009, the House of Commons passed Bill C-15, and it is now awaiting study and approval by the Senate. On December 14, 2009, the Senate passed Bill C-15, with some amendments, for approval by the House of Commons. When the Canadian Parliament dissolved in a prorogation on January 31, 2010, Bill C15, along with all unpassed legislation then tabled before the Commons, fell. Early in 2012, the next parliament passed Bill C-10, receiving Royal Assent in March. The final legislation sees changes made to four areas of the CDSA, outlining mandatory minimum sentences for offences relating to the trafficking and production of various controlled substances. Mandatory minimum sentencing does not apply to simple possession and trafficking in smaller amounts.